FAA Approves Section 333 Exemption for Blue-Chip UAS Across Multiple Industries

Blue-Chip Unmanned Aerial Solutions, Inc. (Blue-Chip UAS) is the first company in the U.S. to receive Federal Aviation Administration (FAA) approval for Section 333 exemption across multiple industries.

Blue-Chip UAS received the coveted authorization on February 10, 2015 to provide service solutions across the Oil and Gas, Wildlife, Agriculture and Aerial Photography industries utilizing the FAA-certified Sensurion Magpie UAS.

"We are excited by the FAA's decision," said Clint Stevens, Executive Director and Co-Founder, Blue-Chip UAS. "It enables us to leverage our expertise in the UAS industry and integrate the technology to benefit multiple commercial markets."

Blue-Chip UAS notched another industry first, as its Section 333 exemption authorizes UAS flight operations within 5NM of any airport or airfield inside Class E airspace with an approved COA, airport manager approval and issuance of a NOTAM.

"The fact we are approved to operate inside 5NM truly shows the FAA's willingness to continue moving forward with the integration process," Stevens noted.  "This provides our company with a significant opportunity, as it dramatically increases our operational area."

Blue-Chip UAS's initial customer engagement is within the oil and gas exploration industry for Paragon Geophysical. Proof of concept test flights were successfully executed in November of 2014 at the Nellis AFB UAS test range in conjunction with Sensurion Aerospace, Paragon and the Nevada Institute for Autonomous Systems.

"With the approved exemption in hand, Blue-Chip UAS is now poised to move to market," confirmed James Burns, Technology Director and Co-Founder. "This approval enables us to build a solid operational model and employ the Magpie, not only within oil and gas, but in several other industries as well. We intend to build on that model and integrate swappable sensor payloads to meet any requirement our customers may have."

Source: http://www.blue-chipuas.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.